Liskantin en es it fr

Liskantin Brand names, Liskantin Analogs

Liskantin Brand Names Mixture

  • No information avaliable

Liskantin Chemical_Formula


Liskantin RX_link

Liskantin fda sheet

Liskantin msds (material safety sheet)

Liskantin MSDS

Liskantin Synthesis Reference

Boon et al., Brit. pat. 666,027 (1952 to I.C.I.)

Liskantin Molecular Weight

218.252 g/mol

Liskantin Melting Point

281.5 oC

Liskantin H2O Solubility

500 mg/L

Liskantin State


Liskantin LogP


Liskantin Dosage Forms

Tablet; Chewable tablets; Oral suspension

Liskantin Indication

For the treatment of epilepsy

Liskantin Pharmacology

Primidone is a barbiturate with anticonvulsant properties. Primidone, either alone or used concomitantly with other anticonvulsants, is indicated in the control of grand mal, psychomotor, and focal epileptic seizures. It may control grand mal seizures refractory to other anticonvulsant therapy. Primidone raises electro- or chemoshock seizure thresholds or alters seizure patterns in experimental animals. Primidone per se has anticonvulsant activity as do its two metabolites, phenobarbital and phenylethylmalonamide (PEMA). In addition to its anticonvulsant activity, Primidone potentiates that of phenobarbital in experimental animals.

Liskantin Absorption

90 to 100%

Liskantin side effects and Toxicity

No information avaliable

Liskantin Patient Information

Liskantin Organisms Affected

Humans and other mammals